Dr. med. univ. Michael Messner

Wichtigste Publikationen

  1. Morbus Parkinson und Restless-legs-Syndrom – ein unterschätztes Problem?
    Nervenheilkunde, October 2021
  2. Clincial exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up
  3. Movement Disorders, September 2016
    Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controls
  4. Parkinsonism & Related Disorders, July 2016
  5. The continuous subcutaneous apomorphine infusionNervenheilkunde, January 2015
  6. Quality survey using the patient reported activity of living questionnaire of the new MDS-UPDRS
    Nervenheilkunde , January 2015
  7. Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation
    Journal of Neural Transmission, April 2014
  8. Long-term efficacy and patient satisfaction of continuous subcutaneous apomorphine infusion
    Basal Ganglia, March 2013
  9. Therapy options with botulinum toxin for patients with Parkinson’s disease
    Nervenheilkunde, January 2013
  10. How dangerous is the therapeutic application of botulinum toxin?
    Nervenheilkunde, January 2009
  11. Botulinumtoxin – Therapeutischer Einsatz bei Bewegungsstörungen
    Psychoneuro, January 2008
  12. Therapy with botulinum toxin in patients with spasticity
    Nervenheilkunde, January 2008
  13. Medikamentöse Therapie des Parkinson Syndroms
    Notfall & Hausarztmedizin, October 2006
  14. Update zur medikamentösen Therapie des idiopathischen Parkinson-Syndroms (IPS)
    Psychoneuro, September 2006